Dermapharm Holding

Dermapharm is a leading German manufacturer of off-patent branded pharmaceuticals and other healthcare products. The company operates a diverse portfolio focusing on therapeutic areas such as dermatology, allergy treatment, and vitamin supplements, with its flagship product Dekristol being a market leader in Vitamin D therapy. Dermapharm follows an integrated business model that includes in-house development, certified GMP manufacturing, and a robust distribution network. In addition to its branded business, the company is a significant player in the parallel import of originators and provides contract manufacturing services, notably partnering with BioNTech for COVID-19 vaccine production. The group has expanded significantly through strategic acquisitions, including Arkopharma and Euromed, to strengthen its position in the herbal extracts and nutraceuticals markets.